MicroRNAs as circulating biomarkers in acute coronary syndromes: A review

Vascular Pharmacology

Volumn 81, Issue , 2016, Pages 15-21

  Ahlin, Fredrik ^a,b   Arfvidsson, John ^a,b   Vargas, Kris G ^a   Stojkovic, Stefan ^c,d   Huber, Kurt ^a,d,e   Wojta, Johann ^c,d  

^a WILHELMINEN HOSPITAL   (Austria)

^b LINKÖPING UNIVERSITY   (Sweden)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

^e SIGMUND FREUD UNIVERSITY   (Austria)

Author keywords

Acute coronary syndrome; Biomarker; MicroRNA; Troponin

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; TROPONIN; GENETIC MARKER;

ACUTE CORONARY SYNDROME; CARDIAC PATIENT; CORONARY ARTERY DISEASE; EMERGENCY WARD; HEART INFARCTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; RISK ASSESSMENT; THORAX PAIN; ANIMAL; BLOOD; CORONARY RESTENOSIS; GENETIC MARKER; GENETICS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS;

ACUTE CORONARY SYNDROME; ANIMALS; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; GENETIC MARKERS; HUMANS; MICRORNAS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TROPONIN;

EID: 84963944150     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2016.04.001     Document Type: Review

References (41)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Boon R.A., Vickers K.C. Intercellular transport of microRNAs. Arterioscler. Thromb. Vasc. Biol. 2013, 33:186-192.
3. Chen M.S., John J.M., Chew D.P., Lee D.S., Ellis S.G., Bhatt D.L. Bare metal stent restenosis is not a benign clinical entity. Am. Heart J. 2006, 151:1260-1264.
4. Cheng C., Wang Q., You W.J., Chen M.H., Xia J.H. MiRNAs as biomarkers of myocardial infarction: a meta analysis. PLoS One 2014, 9.
5. D'Alessandra Y., Carena M.C., Spazzafumo L., Martinelli F., Bassetti B., Devanna P., et al. Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PLoS One 2013, 8.
6. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P.G., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur. Heart J. 2010, 31:2765-2773.
7. Devaux Y., Mueller M., Haaf P., Goretti E., Twerenbold R., Zangrando J., et al. Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J. Intern. Med. 2015, 277:260-271.
8. Devaux Y., Vausort M., Goretti E., Nazarov P.V., Azuaje F., Gilson G., et al. Use of circulating MicroRNAs to diagnose acute myocardial infarction. Clin. Chem. 2012, 58:559-567.
9. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., et al. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107:677-684.
10. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 2006, 48:193-202.
11. Lenfant C. Chest pain of cardiac and noncardiac origin. Metab. Clin. Exp. 2010, 59(Suppl. 1):S41-S46.
12. Li X., Yang Y., Wang L., Qiao S., Lu X., Wu Y., et al. Plasma miR-122 and miR-3149 potentially novel biomarkers for acute coronary syndrome. PLoS One 2015, 10.
13. Li Y.Q., Zhang M.F., Wen H.Y., Hu C.L., Liu R., Wei H.Y., et al. Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics (Sao Paulo) 2013, 68:75-80.
14. Lindsell C.J., Anantharaman V., Diercks D., Han J.H., Hoekstra J.W., Hollander J.E., et al. The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. Ann. Emerg. Med. 2006, 48:666-677. (677 e661-669).
15. Lipinski M.J., Escarcega R.O., D'Ascenzo F., Magalhaes M.A., Baker N.C., Torguson R., et al. A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am. J. Cardiol. 2014, 113:1581-1591.
16. Mayr M., Zampetaki A., Willeit P., Willeit J., Kiechl S. MicroRNAs within the continuum of postgenomics biomarker discovery. Arterioscler. Thromb. Vasc. Biol. 2013, 33:206-214.
17. McCann C.J., Glover B.M., Menown I.B., Moore M.J., McEneny J., Owens C.G., et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur. Heart J. 2008, 29:2843-2850.
18. McDonald R.A., Halliday C.A., Miller A.M., Diver L.A., Dakin R.S., Montgomery J., et al. Reducing in-stent restenosis: therapeutic manipulation of miRNA in vascular remodeling and inflammation. J. Am. Coll. Cardiol. 2015, 65:2314-2327.
19. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518.
20. Möckel M., Giannitsis E., Mueller C., Huber K., Jaffe A.S., Mair J., et al. Rapid rule-in of patients with suspected acute myocardial infarction: focus on troponin. Eur. Heart J. Acute Cardiovasc. Care 2016, (in press).
21. Mockel M., Searle J., Hamm C., Slagman A., Blankenberg S., Huber K., et al. Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur. Heart J. 2015, 36:369-376.
22. Oerlemans M.I., Mosterd A., Dekker M.S., de Vrey E.A., van Mil A., Pasterkamp G., et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol. Med. 2012, 4:1176-1185.
23. Olivieri F., Antonicelli R., Lorenzi M., D'Alessandra Y., Lazzarini R., Santini G., et al. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int. J. Cardiol. 2013, 167:531-536.
24. Pratt A.J., MacRae I.J. The RNA-induced silencing complex: a versatile gene-silencing machine. J. Biol. Chem. 2009, 284:17897-17901.
25. Quiat D., Olson E.N. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J. Clin. Invest. 2013, 123:11-18.
26. Reichlin T., Schindler C., Drexler B., Twerenbold R., Reiter M., Zellweger C., et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch. Intern. Med. 2012, 172:1211-1218.
27. Ren J., Zhang J., Xu N., Han G., Geng Q., Song J., et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One 2013, 8.
28. Rubini Gimenez M., Twerenbold R., Jaeger C., Schindler C., Puelacher C., Wildi K., et al. One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I. Am. J. Med. 2015, 128(861-870).
29. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91:827-887.
30. Serruys P.W., Kutryk M.J., Ong A.T. Coronary-artery stents. N. Engl. J. Med. 2006, 354:483-495.
31. Small E.M., Olson E.N. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011, 469:336-342.
32. Thygesen K., Alpert J.S., Jaffe A.S., Simoons M.L., Chaitman B.R., White H.D., et al. Third universal definition of myocardial infarction. Eur. Heart J. 2012, 33:2551-2567.
33. Wang G.K., Zhu J.Q., Zhang J.T., Li Q., Li Y., He J., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur. Heart J. 2010, 31:659-666.
34. Ward J.A., Esa N., Pidikiti R., Freedman J.E., Keaney J.F., Tanriverdi K., et al. Circulating cell and plasma microRNA profiles differ between non-ST-segment and ST-segment-elevation myocardial infarction. Fam. Med. Med. Sci. Res. 2013, 2:108.
35. White H.D., Thygesen K., Alpert J.S., Jaffe A.S. Clinical implications of the Third Universal Definition of Myocardial Infarction. Heart 2014, 100:424-432.
36. Widera C., Gupta S.K., Lorenzen J.M., Bang C., Bauersachs J., Bethmann K., et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J. Mol. Cell. Cardiol. 2011, 51:872-875.
37. World Health Organization The Top 10 Causes of Death 2014.
38. Xu R.Y., Zhu X.F., Yang Y., Ye P. High-sensitive cardiac troponin T. J. Geriatr. Cardiol. 2013, 10:102-109.
39. Zampetaki A., Willeit P., Drozdov I., Kiechl S., Mayr M. Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc. Res. 2012, 93:555-562.
40. Zeller T., Keller T., Ojeda F., Reichlin T., Twerenbold R., Tzikas S., et al. Assessment of microRNAs in patients with unstable angina pectoris. Eur. Heart J. 2014, 35:2106-2114.
41. Zhong J., He Y., Chen W., Shui X., Chen C., Lei W. Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. Int. J. Mol. Sci. 2014, 15:20355-20364.